Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- The Wall Street Journal: FBI Deputy Director McCabe fired two days before retirement date - March 16, 2018
- Financial News: Freeze the assets of Putin’s allies, U.K, U.S. lawmakers say: it’s ‘the only way to change the behavior of evil regimes’ - March 16, 2018
- Qualcomm shuts Jacobs out of board election on takeover plans - March 16, 2018